Novel Safe Potent Precisely Attenuated Mycobacterium Tuberculosis Vaccine Against Tuberculosis (UCLA Case No. 2026-109)

Details available soon. Please contact UCLA Technology Development Group if you have any questions or would like more information in the meantime.

Patent Information:
For More Information:
Thibault Renac
Business Development Officer
Thibault.Renac@tdg.ucla.edu
Inventors:
Marcus Horwitz